Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

Expanding Access to Care: Ohio’s Effort to Modernize APRN Practice Through Ohio SB 258 and HB 508

Client Alert

Ohio has been facing a growing healthcare challenge for years: not enough providers to meet the needs of our communities, especially in rural and underserved areas. Two new bills, Ohio Senate Bill 258 and Ohio House Bill 508, offer a potential solution by modernizing how certain Advanced Practice Registered Nurses (“APRNs”), such as nurse practitioners, certified nurse midwives, and clinical nurse specialists, are allowed to practice in our state.

These bills, known collectively as the Better Access to Health Care Act, would eliminate the outdated requirement that APRNs enter into a written contract called a “Standard Care Arrangement” (SCA) with a collaborating physician in order to provide care. This bureaucratic hurdle doesn’t reflect the training and expertise that APRNs possess, and it limits patient access to timely, affordable, high-quality care. For the many APRN-owned practices that exist in Ohio, the SCA requirement also creates a regulatory barrier that increases the cost of owning a business in Ohio.

Why This Matters:

  • More Providers = Better Access
    Lifting the SCA requirement would allow APRNs to practice with fewer barriers, meaning more clinics in rural areas, shorter wait times, and faster treatment for patients who need it most. In certain areas of Ohio, an APRN is the only available healthcare provider for the entire area.

  • APRNs Are Highly Trained
    APRNs are advanced-degree nurses who undergo rigorous clinical and academic training. In over half of the states, APRNs already practice without any regulatorily prescribed relationship with a physician, and studies show that care APRNs provide is safe, effective, and well-received by patients.

  • Reducing Costs Without Sacrificing Quality
    Allowing APRNs to practice to the full extent of their training helps reduce health care costs while maintaining high standards of care. More access to primary care means fewer ER visits and lower costs for the health system overall. Recent studies also show that retiring the mandated SCA has not resulted in any adverse impact on the quality of patient care in other states.[1]

  • Federal Trade Commission (“FTC”) Support
    Since 2014, the FTC has continually issued guidance stating that regulations that mandate contracts such as the SCA are a restraint of trade.[2]  The FTC has advised, including in prior commentary specific to Ohio, that APRNs should be free to practice without any mandated contract with a physician.[3] 

  • Bipartisan Support
    Both bills are backed by legislators in the Ohio House and Senate from both parties, showing that this is not a partisan issue; it’s a common-sense policy change supported by health care experts and patient advocates alike.

Passing SB 258 and HB 508 won’t just support nurses; it will support patients, families, businesses, and communities across Ohio. These bills are a long-overdue step toward a more flexible, efficient, and patient-centered health care system.

Let’s give APRNs the tools they need to serve Ohioans, and let’s make sure every patient has access to the care they deserve.

To learn more about Ohio SB 258 and Ohio HB 508 or the Ohio laws and regulations that govern APRN practice, please contact BMD Member Jeana Singleton at jmsingleton@bmdllc.com.


[1] Markowitz et al., “Nurse Practitioner Scope of Practice and Patient Harm,” NBER Working Paper No. 31109 (2023); Journal of Policy Analysis and Management (2023).  See “A Comparative Analysis of NP, PA, and Physician Malpractice Risk,” Journal of the American Association of Nurse Practitioners, Vol. 37, Issue 6 (2025). See also, Myers et al., Advanced Practice Provider Malpractice Claims, Journal of Healthcare Risk Management (2021).

[2] Federal Trade Commission, Policy Perspectives: Competition and the Regulation of Advanced Practice Nurses, March 2014, https://www.ftc.gov/system/files/documents/reports/policy-perspectives-competition-regulation-advanced-practice-nurses/140307aprnpolicypaper.pdf (last accessed 10/22/2025). 

[3] Federal Trade Commission, Letter to Ohio House of Representatives re: Ohio HB 177, January 2020, https://www.ftc.gov/system/files/documents/advocacy_documents/ftc-staff-comment-ohio-house-representatives-concerning-ohio-house-bill-177/v200005ohiohb177aprnscomment.pdf (last accessed 10/22/2025). 


CMS Releases CY 2026 Medicare Physician Fee Schedule Final Rule with Key Payment and Telehealth Updates

CMS issued the CY 2026 Medicare Physician Fee Schedule Final Rule on October 31, 2025, with changes effective January 1, 2026. The Final Rule includes increases to the conversion factor, a new efficiency adjustment, updates to practice expense methodology, permanent telehealth policy changes, revised payment for skin substitutes, expanded rules for Part B drugs and biologicals, enhanced policies for Rural Health Clinics and Federally Qualified Health Centers, and new care management and behavioral health services.

Ohio Department of Medicaid Updates: Key Changes to Physician Reimbursement Rates in Early Parenthood

The Ohio Department of Medicaid has proposed amending Ohio Administrative Code Rule related to covered Medicaid reimbursements for physicians. Beginning on January 1, 2026, they are proposing an increase to rates for prenatal care, childbirth, and infant care and provider visits.

Name, Image, and Likeness Agreements in Healthcare

For example, some healthcare providers have begun to utilize "Name, Image, and Likeness" agreements to promote the brand they have created through their healthcare practice.  We have seen the most healthcare NIL activity with longevity and wellness providers, as well as orthopedics.

Compounding GLP-1 Drugs - Recent Updates

Recent guidance from the Ohio Board of Pharmacy (“BOP”) indicates that providers should generally use the FDA approved GLP-1 drug, rather than a non-FDA approved compounded version of the medication. Importantly, if a GLP-1 drug is commercially available, it cannot be copied through compounding. Currently, compounded copies of Tirzepatide and Semaglutide are not permitted.

Top Compliance Risks for Ohio Med-Spas in 2025

The Ohio Board of Pharmacy has increased inspections of med-spas holding Terminal Distributor of Dangerous Drugs (TDDD) licenses, with many facing enforcement actions in 2025. Common issues include purchasing from unlicensed distributors, improper drug storage, inadequate recordkeeping, and insufficient prescriber oversight. Understanding these risks and maintaining compliance can help protect your practice from penalties and license suspension.